Cooperative Agreement UG3DA063084
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$873K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Cooperative Agreement
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The study aims to: 1) characterize real-world trajectories of OUD treatment in the year following hospital encounters among treatment-naive individuals and...
This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $2,437,310 project at the University of California, San Diego (UCSD) to prospectively study the intersection between substance use, HIV, and related comorbidities in a binational cohort of people who inject drugs (PWID) in San Diego County. The 5-year project aims to track emerging substance use trends and evaluate the impact of harm...
This Cooperative Agreement award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and validate a novel patient-reported outcome measure of substance-related consequences for use in substance use disorder (SUD) treatment trials. The $352,064 award, effective from August 1, 2025 to July 31, 2027, will be executed by the Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $1,088,999 Project Grant to The Trustees of Columbia University in the City of New York, effective August 15, 2024 through May 31, 2029. The objective of this project is to develop efficient statistical estimators for analyzing data fusion of multi-study, multi-outcome clinical trials for treating opioid use disorder. The project aims to: 1) create parametric and...
This federal Project Grant award of $157,684, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to understand inequities in harm reduction services (HRS) provided to persons with opioid use disorder in hospital settings. The study will use natural language processing (NLP) and electronic health record (EHR) data to characterize providers' recommendations of psychosocial/environmental and...
This federal Cooperative Agreement award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and validate a Clinical Outcomes Assessment (COA) for opioid withdrawal management. The $702,974 award, effective June 15, 2025 through May 31, 2027, will support the Research Foundation of the City University of New York (RFCUNY) in an iterative process to expand upon existing withdrawal scales, integrate insights...
The Federal Project Grant award R01DA061228, totaling $2,246,842.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports the "Improving Health and Housing Outcomes through a Simulation and Economic Model (IHOUSE Model)" project, which aims to develop agent-based models to simulate health outcomes and racial/ethnic disparities among people experiencing homelessness in Denver and San Francisco....
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
The National Institute on Drug Abuse (NIDA) awarded a $306,528 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Addinex Technologies, Inc. The grant will fund the development of a medication adherence and monitoring system to support decentralized clinical trials for substance use disorder (SUD). The project aims to adapt Addinex's existing medication management system to provide researchers running SUD clinical trials with a tool for at-home dispensing that...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to develop novel methods for estimating the prevalence of drug use among older adults in New York City. The $960,696 award to New York University will administer a rapid drug survey and conduct saliva and hair testing on 300 adults aged 65+ to determine the extent to which biological testing adds to self-reported drug use data. The...